Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 16 ... candidates addressing the treatment of cystic fibrosis, bronchiectasis, inhalation anthrax infections and smoking cessation. Aradigm, AERx, and the Aradigm Logo are ...
2009 NOV 23 ... MIF inhibitor program to Novartis International Pharmaceuticals Ltd. and has sold its anthrax monoclonal antibody program to Emergent BioSolutions. The Company's first ...
2009 NOV 16 ... ongoing development work on several of our vaccine and therapeutic candidates in our anthrax program under various development contracts and grants with NIAID. We also continue to ...
2009 NOV 9 ... development pipeline includes novel drugs to treat lupus, hepatitis C, inhalation anthrax and cancer. The Company's primary focus is rapid progress toward the ...
2009 NOV 2 ... from the United States, "Proteolytically activated Protective Antigen (PA) moiety of anthrax toxin self-associates to form a heptameric ring-shaped oligomer (the prepore). Acidic pH ...
2009 NOV 29 ... in our environment, can also cause serious infectious diseases, such as tetanus, anthrax, and botulism. Now researchers from Lund University and the U.S. have made a ...
2009 NOV 23 ... extent, of activities related to RypVax™ and the Company's third generation rPA anthrax vaccine program. General and administrative expenses were $6.2 million and ...
2009 NOV 23 ... are being vaccinated during child-bearing years, including vaccination with BioThrax (Anthrax Vaccine Adsorbed, or AVA). As only a limited number of studies exist in humans that have ...
2009 NOV 9 ... to a study from the United States, "Protective antigen (PA), the binding subunit of anthrax toxin, is the major component in the current anthrax ...
2009 NOV 2 ... the test of time." "For decades, scholars have reported that the human anthrax vaccine field trials conducted in the 1950s by Brachman and his colleagues were ...
2009 NOV 23 ... of West Nile Virus, and Biodefense applications including the rapid on-site detection of anthrax, smallpox, ricin and botulinum toxin. Several other product applications are under ...
2009 NOV 2 ... of West Nile Virus, and Biodefense applications including the rapid on-site detection of anthrax, smallpox, ricin and botulinum toxin. Several other product applications are under ...
2009 NOV 9 ... Infection and Immunity, "Three chimpanzee Fabs reactive with lethal factor (LF) of anthrax toxin were isolated and converted into complete monoclonal antibodies (MAbs) with human ...
2009 NOV 9 ... effective tool for the rapid onsite detection of up to five biological warfare agents: anthrax, ricin, botulinum toxin, Y. pestis (plague) and Staphylococcal Enterotoxin B (SEB). ...
2009 NOV 9 ... study from the intelligence community projected that a two-to-four pound release of anthrax spores from a crop duster plane could kill more Americans than died in World War II. ...
Subject: Commission on the Prevention of Weapons of Mass Destruction Proliferation and Terrorism
